Dave Inc (DAVE)vsZepp Health Corp (ZEPP)
DAVE
Dave Inc
$271.99
+5.72%
TECHNOLOGY · Cap: $3.41B
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Dave Inc generates 114% more annual revenue ($554.18M vs $258.90M). DAVE leads profitability with a 35.3% profit margin vs -15.5%. DAVE earns a higher WallStSmart Score of 70/100 (B).
DAVE
Strong Buy70
out of 100
Grade: B
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+12.5%
Fair Value
$193.93
Current Price
$271.99
$78.06 discount
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 73 in profit
Keeps 35 of every $100 in revenue as profit
Strong operational efficiency at 39.4%
Revenue surging 62.4% year-over-year
Earnings expanding 292.4% YoY
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Trading at 10.4x book value
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : DAVE
The strongest argument for DAVE centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 35.3% and operating margin at 39.4%. Revenue growth of 62.4% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : DAVE
The primary concerns for DAVE are Price/Book.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
DAVE profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
DAVE carries more volatility with a beta of 3.82 — expect wider price swings.
DAVE is growing revenue faster at 62.4% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DAVE scores higher overall (70/100 vs 41/100), backed by strong 35.3% margins and 62.4% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Dave Inc
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Dave Inc. (Ticker: DAVE) is a U.S.–based financial technology (fintech) and digital banking company that offers consumer-focused financial products and services through its mobile platform. Its offerings include budgeting tools to help users manage income and expenses, ExtraCash short-term cash advances, digital checking accounts via Dave Banking, and a job-finding feature called Side Hustle. The company’s platform aims to provide accessible, modern financial solutions designed as alternatives to traditional banking fees and overdraft charges.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?